On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing
On November 22, Oncternal Therapeutics Announced That Nasdaq Plans To Delist Its Stock On December 3, Nasdaq Classified The Company As "Public Shell," Following Its Decision To Lay Off Employees And Explore Strategic Alternatives-Filing
11月22日,oncternal therapeutics宣布纳斯达克计划在12月3日将其股票摘牌,纳斯达克将该公司归类为“公共外壳公司”,这是在其决定裁员并探索战略替代方案之后的决定-提交文件
Nasdaq will file a delisting notice with the SEC. Oncternal has stated it will not appeal the decision.
纳斯达克将向美国证券交易委员会提交摘牌通知。oncternal已表示将不对该决定提出上诉。